# Docebo Inc.: financial statements, quarterly

DCBO · Nasdaq · CIK 1829959 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dcbo.md) · [Financials](/companies/dcbo/financials.md) · [Filings](/companies/dcbo/filings.md) · [Insiders](/companies/dcbo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dcbo/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2018-12-31) | period not labelled (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [3.8](/filings/0001829959-21-000009.md) | [46.3](/filings/0001628280-22-005638.md) | [220](/filings/0001628280-23-007142.md) | [215](/filings/0001628280-24-006515.md) | [216](/filings/0001628280-25-008863.md) | [72.0](/filings/0001628280-26-012566.md) | [92.5](/filings/0001628280-26-012566.md) | [74.0](/filings/0001628280-26-012566.md) |
| Current assets | $m | not reported | [58.9](/filings/0001829959-21-000009.md) | [240](/filings/0001628280-22-005638.md) | [252](/filings/0001628280-23-007142.md) | [264](/filings/0001628280-24-006515.md) | [127](/filings/0001628280-25-008863.md) | [154](/filings/0001628280-26-012566.md) | [152](/filings/0001628280-26-012566.md) |
| Total assets | $m | not reported | [63.9](/filings/0001829959-21-000009.md) | [254](/filings/0001628280-22-005638.md) | [268](/filings/0001628280-23-007142.md) | [284](/filings/0001628280-24-006515.md) | [158](/filings/0001628280-25-008863.md) | [191](/filings/0001628280-26-012566.md) | [207](/filings/0001628280-26-012566.md) |
| Current liabilities | $m | not reported | [28.5](/filings/0001829959-21-000009.md) | [45.7](/filings/0001628280-22-005638.md) | [69.3](/filings/0001628280-23-007142.md) | [84.4](/filings/0001628280-24-006515.md) | [101](/filings/0001628280-25-008863.md) | [129](/filings/0001628280-26-012566.md) | [124](/filings/0001628280-26-012566.md) |
| Total liabilities | $m | not reported | [32.5](/filings/0001829959-21-000009.md) | [53.9](/filings/0001628280-22-005638.md) | [77.6](/filings/0001628280-23-007142.md) | [91.5](/filings/0001628280-24-006515.md) | [108](/filings/0001628280-25-008863.md) | [133](/filings/0001628280-26-012566.md) | [133](/filings/0001628280-26-012566.md) |
| Shareholders' equity | $m | [(16.8)](/filings/0001829959-21-000009.md) | [31.4](/filings/0001628280-22-005638.md) | [200](/filings/0001628280-23-007142.md) | [191](/filings/0001628280-24-006515.md) | [192](/filings/0001628280-25-008863.md) | [50.7](/filings/0001628280-26-012566.md) | [57.8](/filings/0001628280-26-012566.md) | [74.1](/filings/0001628280-26-012566.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity

Shares outstanding: 28,747,289 at 2025-12-31, from the cover of the [40-F filed 2026-02-27](/filings/0001628280-26-012566.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.